US Patent 8501724 Purinone compounds as kinase inhibitors
Patent 8501724 was granted and assigned to Pharmacyclics on August, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 21 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 14 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08501724 Purinone compounds as kinase inhibitors US Patent 8501724 Purinone compounds as kinase inhibitors
Infobox
Patent Number
08501724
Patent Number
8501724
Edits on 17 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08501724 Purinone compounds as kinase inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08501724
Date of patent
August 6, 2013
Patent application number
13460524
Date Filed
April 30, 2012
Patent primary examiner
Find more entities like US Patent 8501724 Purinone compounds as kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
